Implication of intestinal barrier dysfunction in gut dysbiosis and diseases

C Stolfi, C Maresca, G Monteleone, F Laudisi - Biomedicines, 2022 - mdpi.com
The intestinal mucosal barrier, also referred to as intestinal barrier, is widely recognized as a
critical player in gut homeostasis maintenance as it ensures the complex crosstalk between …

Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues

SK Lai, YY Wang, J Hanes - Advanced drug delivery reviews, 2009 - Elsevier
Mucus is a viscoelastic and adhesive gel that protects the lung airways, gastrointestinal (GI)
tract, vagina, eye and other mucosal surfaces. Most foreign particulates, including …

Enzymatically active biomimetic micropropellers for the penetration of mucin gels

D Walker, BT Käsdorf, HH Jeong, O Lieleg… - Science …, 2015 - science.org
In the body, mucus provides an important defense mechanism by limiting the penetration of
pathogens. It is therefore also a major obstacle for the efficient delivery of particle-based …

Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier

BC Tang, M Dawson, SK Lai… - Proceedings of the …, 2009 - National Acad Sciences
Protective mucus coatings typically trap and rapidly remove foreign particles from the eyes,
gastrointestinal tract, airways, nasopharynx, and female reproductive tract, thereby strongly …

Mucus as a barrier to lipophilic drugs

HH Sigurdsson, J Kirch, CM Lehr - International journal of pharmaceutics, 2013 - Elsevier
Mucus is a complex hydrogel, comprising glycoproteins, lipids, salts, DNA, enzymes and
cellular debris, covering many epithelial surfaces in the human body. Once secreted, mucin …

Pulmonary delivery nanomedicines towards circumventing physiological barriers: Strategies and characterization approaches

W Wang, Z Huang, Y Huang, X Zhang, J Huang… - Advanced Drug Delivery …, 2022 - Elsevier
Pulmonary delivery of nanomedicines is very promising in lung local disease treatments
whereas several physiological barriers limit its application via the interaction with inhaled …

Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy

P Mastorakos, AL Da Silva… - Proceedings of the …, 2015 - National Acad Sciences
Gene therapy has emerged as an alternative for the treatment of diseases refractory to
conventional therapeutics. Synthetic nanoparticle-based gene delivery systems offer highly …

New and emerging targeted therapies for cystic fibrosis

BS Quon, SM Rowe - Bmj, 2016 - bmj.com
Cystic fibrosis (CF) is a monogenic autosomal recessive disorder that affects about 70 000
people worldwide. The clinical manifestations of the disease are caused by defects in the …

[HTML][HTML] Developments of mucus penetrating nanoparticles

M Liu, J Zhang, W Shan, Y Huang - Asian Journal of Pharmaceutical …, 2015 - Elsevier
Mucus can effectively protect the exposed mucosal surfaces due to its adhesive and
viscoelastic properties. Most foreign particulates are efficiently trapped in mucus layers via …

Enhanced viscoelasticity of human cystic fibrotic sputum correlates with increasing microheterogeneity in particle transport

M Dawson, D Wirtz, J Hanes - Journal of Biological Chemistry, 2003 - ASBMB
Current biochemical characterizations of cystic fibrosis (CF) sputum do not address the high
degree of microheterogeneity in the rheological properties of the mucosal matrix and only …